A detailed history of Prosperity Consulting Group, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Prosperity Consulting Group, LLC holds 28,564 shares of GILD stock, worth $2.52 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
28,564
Previous 36,370 21.46%
Holding current value
$2.52 Million
Previous $2.5 Million 4.05%
% of portfolio
0.19%
Previous 0.35%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$66.59 - $83.99 $519,801 - $655,625
-7,806 Reduced 21.46%
28,564 $2.39 Million
Q2 2024

Aug 08, 2024

SELL
$63.15 - $72.88 $1.05 Million - $1.21 Million
-16,615 Reduced 31.36%
36,370 $2.5 Million
Q1 2024

May 01, 2024

BUY
$71.58 - $87.29 $3.5 Million - $4.26 Million
48,832 Added 1175.82%
52,985 $3.88 Million
Q4 2023

Feb 13, 2024

BUY
$73.27 - $83.09 $304,290 - $345,072
4,153 New
4,153 $336,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Prosperity Consulting Group, LLC Portfolio

Follow Prosperity Consulting Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prosperity Consulting Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prosperity Consulting Group, LLC with notifications on news.